Technical Analysis for KZR - Kezar Life Sciences, Inc.

Grade Last Price % Change Price Change
grade F 21.96 8.12% 1.65
KZR closed up 8.12 percent on Friday, February 15, 2019, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Up
See historical KZR trend table...

Date Alert Name Type % Chg
Feb 15 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Feb 15 Pocket Pivot Bullish Swing Setup 0.00%
Feb 15 Stochastic Reached Overbought Strength 0.00%
Feb 15 Earnings Movers Other 0.00%
Feb 15 Weak + Overbought Other 0.00%
Feb 15 Above Upper BB Strength 0.00%
Feb 15 Overbought Stochastic Strength 0.00%
Feb 15 Up 3 Days in a Row Strength 0.00%
Feb 15 Up 4 Days in a Row Strength 0.00%
Feb 15 Up 5 Days in a Row Strength 0.00%

Older signals for KZR ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:

Profile
  • Earnings date: 2019-02-14
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer.
Biotechnology Cancer Life Sciences Pharmaceutical Companies
Is KZR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Dec 20 These 4 Biotech Stocks are Picking Up Speed
Dec 20 Healthcare & Tech dominate midday movers
Dec 14 The Daily Biotech Pulse: Axovant In-Licenses 2 Gene Therapies, Agile To Undertake Additional Study Of Contraceptive Patch
Dec 13 XPO, LLNW and TLRD among notable midday movers
Dec 13 Kezar Life Sciences adds to up move, shares ahead 16%
Dec 13 Adial Pharmaceuticals leads healthcare gainers; Marinus Pharmaceuticals and Applied Genetic Technologies among losers
Dec 5 Kezar Life Sciences to Present at The BMO Prescriptions for Success Healthcare Conference
Nov 26 Here's how much better insiders have profited from this year's IPO boom
Nov 8 Kezar Life Sciences beats by $0.18
Nov 8 Kezar Life Sciences Reports Third Quarter 2018 Financial Results and Provides Business Update
See more KZR news...
Indicators
Indicator Value
52 Week High 36.33
52 Week Low 14.77
Average Volume 56,485
200-Day Moving Average 0.0
50-Day Moving Average 22.1488
20-Day Moving Average 18.973
10-Day Moving Average 19.19
Average True Range 1.3958
ADX 15.52
+DI 28.2251
-DI 14.1192
Chandelier Exit (Long, 3 ATRs ) 19.9726
Chandelier Exit (Short, 3 ATRs ) 21.0574
Upper Bollinger Band 21.1975
Lower Bollinger Band 16.7485
Percent B (%b) 1.17
BandWidth 23.449112
MACD Line -0.4865
MACD Signal Line -1.0121
MACD Histogram 0.5256
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.69
Resistance 3 (R3) 24.41 23.21 24.24
Resistance 2 (R2) 23.21 22.52 23.36 24.08
Resistance 1 (R1) 22.59 22.09 22.90 22.87 23.93
Pivot Point 21.39 21.39 21.55 21.54 21.39
Support 1 (S1) 20.77 20.70 21.08 21.05 19.99
Support 2 (S2) 19.57 20.27 19.72 19.84
Support 3 (S3) 18.95 19.57 19.69
Support 4 (S4) 19.23